( en | de | ru )

 

Disambiguation of "McCullough, Peter A."

Author of the publication

copydeleteadd this publication to your clipboard
Clinical outcomes after early ambulatory multidrug therapy for high-risk SARS-CoV-2 (COVID-19) infection

, , , , , and . Reviews in Cardiovascular Medicine, 21 (4): 611 (2020)
DOI: 10.31083/j.rcm.2020.04.260

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

Brian McCullough

Peter A Ehrl

Peter A Schmid

Peter A Wuffli

Peter A Ehrl

 

Other publications of authors with the same name

Randomized Controlled Trials of Early Ambulatory Hydroxychloroquine in the Prevention of COVID-19 Infection, Hospitalization, and Death: Meta-Analysis, , , and . (September 2020)Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection, , , , , , , , , and 13 other author(s). The American Journal of Medicine, 134 (1): 16 - 22 (2021)Patient Discomfort Associated with the Use of Intra-arterial Iodinated Contrast Media: A Meta-Analysis of Comparative Randomized Controlled Trials., and . BMC Medical Imaging, (2011)Effectiveness of Ivermectin-Based Multidrug Therapy in Severe Hypoxic Ambulatory COVID-19 Patients, , , , , , and . (July 2021)Frequentist and Bayesian analysis methods for case series data and application to early outpatient COVID-19 treatment case series, , and . (March 2022)Early Multidrug Outpatient Treatment of SARS-CoV-2 Infection (COVID-19) and Reduced Mortality Among Nursing Home Residents, , , , , , , , , and 1 other author(s). (February 2021)Early multidrug treatment of SARS-CoV-2 (COVID-19) and decreased case fatality rates in Honduras, , , , , and . (July 2021)A Report on Myocarditis Adverse Events in the U.S. Vaccine Adverse Events Reporting System (VAERS) in Association with COVID-19 Injectable Biological Products, and . Current Problems in Cardiology, (2021)Clinical outcomes after early ambulatory multidrug therapy for high-risk SARS-CoV-2 (COVID-19) infection, , , , , and . Reviews in Cardiovascular Medicine, 21 (4): 611 (2020)COVID-19 mRNA Vaccines: Lessons Learned from the Registrational Trials and Global Vaccination Campaign, , , , , , and . Cureus, (January 2024)